Business ❯Finance ❯Stock Market ❯Pharmaceutical Stocks

Moderna

Moderna Cuts 2025 Revenue Forecast by $1 Billion, Shares Drop Over 20%

Moderna Stock Surges After Bird Flu Vaccine Developments and Rising Respiratory Illness Rates